NARI: Inari Medical Company Sales Revenue

Inari Medical, Inc. (NARI) leads the development of minimally invasive thrombectomy systems by investing in unique catheter engineering. The company's sales dynamics clearly confirm the effectiveness of its strategy, with the value stabilizing at 0.57. Supply chain optimization via contract manufacturing ensures stability of supply. Rapid revenue growth is driven by innovations in thrombosis treatment, creating a foundation for future expansion.

Revenue and Sales Volume: Inari Medical (NARI) for 07/04/2022 - 03/01/2025

Comprehensive metric breakdowns and analytics for Inari Medical Corp (NARI)

- stock value and consensus price forecast:

Stock Quotes Inari Medical|NARI - Consensus Target

- market capitalization information:

Market Value Inari|NARI - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share Inari Medical|NARI - Book Capitalization|Market-to-Book Ratio inarimedical.com|NARI - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

NARI - Net Income|Expected Net Income Inari Medical, Inc.|NARI - P/E Multiple|Projected Price to Earnings Ratio Inari Medical Inc|NARI - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple Inari Medical Corp|NARI - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Inari Medical|NARI - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months inarimedical.com|NARI - Earnings per share growth in current year|Net earnings per share change forecast for next year Inari Medical, Inc.

- company sales and revenue statistics:

NARI - Company Revenue|Company Future Sales Volume Inari Medical, Inc.|NARI - P/S Multiple|Market Cap to Future Revenue Ratio Inari

Summary company analysis:NARI Inari Medical, Inc.

Inari Medical, Inc. (NARI) maintains leadership in the mechanical thrombectomy segment via its FlowTriever systems, ensuring a steady capital inflow as reflected in the company's sales volume dynamics. This indicator captures daily product revenue, allowing investors to assess real-time asset liquidity and promptly identify trend reversals to minimize risks during portfolio rebalancing.

Key competitors